The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Inherited germline variants in urothelial cancer: A multicenter whole-exome sequencing analysis.
 
Wendy Kohlmann
Employment - BioFire Diagnostics (I)
 
David Nix
No Relationships to Disclose
 
Aaron Atkinson
No Relationships to Disclose
 
Kenneth M Boucher
No Relationships to Disclose
 
Jill Kolesar
Stock and Other Ownership Interests - Helix Diagnostics
Consulting or Advisory Role - The Jackson Laboratory
Research Funding - ArtemiLife
Patents, Royalties, Other Intellectual Property - Patent pending for a cell based therapy derived from human macrophages
 
Eric A. Singer
Research Funding - Astellas Medivation
 
Stephen B. Edge
Honoraria - North American Center for Continuing Medical Education; North American Center for Continuing Medical Education
Research Funding - Pfizer (Inst)
 
Branda Quintana
No Relationships to Disclose
 
Michelle L. Churchman
No Relationships to Disclose
 
Bingjian Feng
Research Funding - Pfizer (Inst); Pfizer (Inst); Regeneron (Inst)
Patents, Royalties, Other Intellectual Property - The PERCH software, for which I am the inventor, has been non-exclusively licensed to Ambry Genetics for their clinical genetic testing service and research.
 
Laura Graham
No Relationships to Disclose
 
John D. Carpten
Honoraria - Roche
Consulting or Advisory Role - Roche/Genentech; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Methods related to Precision Medicine Know-How.; Royalty for IP (USC 2018-116) from drug licensed by Bridgene Biosciences, Inc.
 
Alejandro Sanchez
No Relationships to Disclose
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Bayer; Cardinal Health; Castle Biosciences; Clovis Oncology; Eisai; EMD Serono; Exelixis; Janssen; Novartis; Pfizer; Roche/Genentech; Seagen; TTC Oncology
Research Funding - Eisai (Inst); Exelixis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Newlink Genetics
 
Lindsey Byrne
No Relationships to Disclose
 
Rohit K. Jain
Honoraria - Alphasights (I)
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; EMD Serono; Gilead Sciences; Pfizer; Seattle Genetics/Astellas; Taiho Oncology (I)
Speakers' Bureau - Gilead Sciences; Seattle Genetics/Astellas
Research Funding - Bristol Myers Squibb
 
Kenneth G. Nepple
No Relationships to Disclose
 
Ahmad Shabsigh
No Relationships to Disclose
 
Jad Chahoud
Consulting or Advisory Role - AVEO; DAVA Pharmaceuticals; Exelixis; Pfizer
 
Sumati Gupta
Stock and Other Ownership Interests - Salarius Pharmaceuticals (I)
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo/Lilly (Inst); Five Prime Therapeutics (Inst); Hoosier Cancer Research Network (Inst); Immunocore (Inst); Incyte (Inst); LSK BioPharma (Inst); MedImmune (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); QED Therapeutics (Inst); Rexahn Pharmaceuticals (Inst); Seagen (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - QED Therapeutics